Squarepoint’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.9K | Sell |
46,461
-2,641
| -5% | -$3.06K | ﹤0.01% | 2595 |
|
|
2025
Q1 | $78.1K | Sell |
49,102
-1,654
| -3% | -$2.63K | ﹤0.01% | 2564 |
|
|
2024
Q4 | $154K | Sell |
50,756
-64,349
| -56% | -$195K | ﹤0.01% | 2446 |
|
|
2024
Q3 | $424K | Sell |
115,105
-33,650
| -23% | -$124K | ﹤0.01% | 1844 |
|
|
2024
Q2 | $608K | Buy |
148,755
+125,649
| +544% | +$514K | ﹤0.01% | 1625 |
|
|
2024
Q1 | $364K | Buy |
+23,106
| New | +$364K | ﹤0.01% | 1831 |
|
|
2023
Q4 | – | Sell |
-45,473
| Closed | -$912K | – | 3040 |
|
|
2023
Q3 | $912K | Sell |
45,473
-34,639
| -43% | -$695K | ﹤0.01% | 1355 |
|
|
2023
Q2 | $2.26M | Buy |
80,112
+63,218
| +374% | +$1.78M | 0.01% | 846 |
|
|
2023
Q1 | $291K | Buy |
+16,894
| New | +$291K | ﹤0.01% | 1693 |
|
|
2022
Q4 | – | Sell |
-29,269
| Closed | -$634K | – | 2682 |
|
|
2022
Q3 | $634K | Buy |
+29,269
| New | +$634K | ﹤0.01% | 1306 |
|
|
2022
Q2 | – | Sell |
-20,679
| Closed | -$954K | – | 2717 |
|
|
2022
Q1 | $954K | Buy |
20,679
+16,091
| +351% | +$742K | ﹤0.01% | 1164 |
|
|
2021
Q4 | $386K | Buy |
+4,588
| New | +$386K | ﹤0.01% | 1747 |
|
|
2021
Q3 | – | Sell |
-19,577
| Closed | -$1.04M | – | 2814 |
|
|
2021
Q2 | $1.04M | Buy |
+19,577
| New | +$1.04M | ﹤0.01% | 1152 |
|
|
2021
Q1 | – | Sell |
-10,825
| Closed | -$562K | – | 3115 |
|
|
2020
Q4 | $562K | Buy |
+10,825
| New | +$562K | ﹤0.01% | 1429 |
|